ATE447953T1 - Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis

Info

Publication number
ATE447953T1
ATE447953T1 AT05772459T AT05772459T ATE447953T1 AT E447953 T1 ATE447953 T1 AT E447953T1 AT 05772459 T AT05772459 T AT 05772459T AT 05772459 T AT05772459 T AT 05772459T AT E447953 T1 ATE447953 T1 AT E447953T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
parasitic diseases
treating leishmaniasis
precursors
prevention
Prior art date
Application number
AT05772459T
Other languages
English (en)
Inventor
Ali Ouaissi
Denis Sereno
Baptiste Vergnes
Original Assignee
Inst Rech Developpement Ird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE447953T1 publication Critical patent/ATE447953T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05772459T 2004-07-19 2005-07-15 Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis ATE447953T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58880204P 2004-07-19 2004-07-19
PCT/EP2005/007715 WO2006008082A1 (en) 2004-07-19 2005-07-15 Pharmaceutical compositions for the treatment of leishmaniasis

Publications (1)

Publication Number Publication Date
ATE447953T1 true ATE447953T1 (de) 2009-11-15

Family

ID=34979717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05772459T ATE447953T1 (de) 2004-07-19 2005-07-15 Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis

Country Status (7)

Country Link
US (1) US20080039430A1 (de)
EP (1) EP1768669B1 (de)
AT (1) ATE447953T1 (de)
BR (1) BRPI0513549A (de)
DE (1) DE602005017629D1 (de)
ES (1) ES2333889T3 (de)
WO (1) WO2006008082A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010054382A1 (en) * 2008-11-10 2010-05-14 Elixir Pharmaceuticals, Inc. Compounds, compositions, and methods for treating malaria or leishmaniasis
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531510B1 (de) 2010-02-01 2014-07-23 Novartis AG Pyrazolo-[5,1b-]oxazol-derivate als crf-1-rezeptor-antagonisten
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302459A (en) * 1980-03-19 1981-11-24 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
US4399151A (en) * 1980-06-16 1983-08-16 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the growth of protozoa
DE3269389D1 (en) * 1981-08-10 1986-04-03 Wellcome Found Pharmaceutical formulations containing antimony
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
ES2180689T3 (es) * 1996-04-19 2003-02-16 Nestle Sa Linea inmortalizada de celulas epiteliales del colon humano.
US6339073B1 (en) * 1997-09-11 2002-01-15 Oxigene, Inc. Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases
US6207879B1 (en) * 1999-05-14 2001-03-27 Dekalb Genetics Corporation Maize RS81 promoter and methods for use thereof
AU4961600A (en) * 1999-06-20 2001-01-09 Elnour Abdel Magid Osman Potentiation of chloroquine

Also Published As

Publication number Publication date
US20080039430A1 (en) 2008-02-14
EP1768669A1 (de) 2007-04-04
EP1768669B1 (de) 2009-11-11
WO2006008082A1 (en) 2006-01-26
BRPI0513549A (pt) 2008-05-06
ES2333889T3 (es) 2010-03-02
DE602005017629D1 (de) 2009-12-24

Similar Documents

Publication Publication Date Title
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SE0202462D0 (sv) Novel use
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
GB0112348D0 (en) Compounds
SE0202429D0 (sv) Novel Compounds
WO2005056524A3 (en) Therapeutic agents useful for treating pain
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
SE9901573D0 (sv) New compounds
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
TW200639159A (en) Treatment of pain
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE0201837D0 (sv) Chemical compounds
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
SE9901572D0 (sv) New compounds
BRPI0415546A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios
WO2005035500A3 (en) Therapeutic agents useful for treating pain
AU2003216965A1 (en) Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima
ATE301997T1 (de) Antivirale therapie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties